News/ News/ R&D Pfizer acquires Therachon and its dwarfism drug George Underwood achondroplasia, M&A, Pfizer, rare disease, Therachon 0 Comment Pfizer has announced it will pay $340 million upfront to snap up rare disease biotech Therachon, which is Share X Pfizer acquires Therachon and its dwarfism drug https://pharmaphorum.com/news/pfizer-acquires-therachon-and-its-dwarfism-drug/
achondroplasia, M&A, Pfizer, rare disease, Therachon
0 Comment
